Current and historical daily PE Ratio for GSTC (
GlobeStar Therapeutics Corp
) from 2011 to Sep 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. GlobeStar Therapeutics stock (GSTC) PE ratio as of Sep 22 2024 is 0.
More Details
GlobeStar Therapeutics Corp (GSTC) PE Ratio (TTM) Chart
GlobeStar Therapeutics Corp (GSTC) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1201
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| GlobeStar Therapeutics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-09-22 | At Loss | 2024-07-19 | At Loss |
| 2024-09-20 | At Loss | 2024-07-18 | At Loss |
| 2024-09-19 | At Loss | 2024-07-17 | At Loss |
| 2024-09-18 | At Loss | 2024-07-16 | At Loss |
| 2024-09-17 | At Loss | 2024-07-15 | At Loss |
| 2024-09-16 | At Loss | 2024-07-12 | At Loss |
| 2024-09-13 | At Loss | 2024-07-11 | At Loss |
| 2024-09-12 | At Loss | 2024-07-10 | At Loss |
| 2024-09-11 | At Loss | 2024-07-09 | At Loss |
| 2024-09-10 | At Loss | 2024-07-08 | At Loss |
| 2024-09-09 | At Loss | 2024-07-05 | At Loss |
| 2024-09-06 | At Loss | 2024-07-03 | At Loss |
| 2024-09-05 | At Loss | 2024-07-02 | At Loss |
| 2024-09-04 | At Loss | 2024-07-01 | At Loss |
| 2024-09-03 | At Loss | 2024-06-28 | At Loss |
| 2024-08-30 | At Loss | 2024-06-27 | At Loss |
| 2024-08-29 | At Loss | 2024-06-26 | At Loss |
| 2024-08-28 | At Loss | 2024-06-25 | At Loss |
| 2024-08-27 | At Loss | 2024-06-24 | At Loss |
| 2024-08-26 | At Loss | 2024-06-21 | At Loss |
| 2024-08-23 | At Loss | 2024-06-20 | At Loss |
| 2024-08-22 | At Loss | 2024-06-18 | At Loss |
| 2024-08-21 | At Loss | 2024-06-17 | At Loss |
| 2024-08-20 | At Loss | 2024-06-14 | At Loss |
| 2024-08-19 | At Loss | 2024-06-13 | At Loss |
| 2024-08-16 | At Loss | 2024-06-12 | At Loss |
| 2024-08-15 | At Loss | 2024-06-11 | At Loss |
| 2024-08-14 | At Loss | 2024-06-10 | At Loss |
| 2024-08-13 | At Loss | 2024-06-07 | At Loss |
| 2024-08-12 | At Loss | 2024-06-06 | At Loss |
| 2024-08-09 | At Loss | 2024-06-05 | At Loss |
| 2024-08-08 | At Loss | 2024-06-04 | At Loss |
| 2024-08-07 | At Loss | 2024-06-03 | At Loss |
| 2024-08-06 | At Loss | 2024-05-31 | At Loss |
| 2024-08-05 | At Loss | 2024-05-30 | At Loss |
| 2024-08-02 | At Loss | 2024-05-29 | At Loss |
| 2024-08-01 | At Loss | 2024-05-28 | At Loss |
| 2024-07-31 | At Loss | 2024-05-24 | At Loss |
| 2024-07-30 | At Loss | 2024-05-23 | At Loss |
| 2024-07-29 | At Loss | 2024-05-22 | At Loss |
| 2024-07-26 | At Loss | 2024-05-21 | At Loss |
| 2024-07-25 | At Loss | 2024-05-20 | At Loss |
| 2024-07-24 | At Loss | 2024-05-17 | At Loss |
| 2024-07-23 | At Loss | 2024-05-16 | At Loss |
| 2024-07-22 | At Loss | 2024-05-15 | At Loss |
GlobeStar Therapeutics Corp (GSTC) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
GlobeStar Therapeutics Corp
NAICS : 325412
SIC : 2834
ISIN : US03476L1026
Description
GlobeStar Therapeutics Corp is a clinical-stage Pharmaceutical Company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers